Trends and challenges of AAV-delivered gene editing therapeutics for CNS disorders: Implications for neurodegenerative disease
Open Access
- 17 July 2025
- journal article
- review article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 36 (3) , 102635
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Aging (R41 AG077992)
- National Institute on Aging (R01 AG057522)
- National Institute on Aging (RF1 AG077695)
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (RF1-NS113548-01A1)
This publication has 250 references indexed in Scilit:
- Overexpression of human α-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cellsBrain Research, 2000
- Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerizationNature Medicine, 2000
- A Drosophila model of Parkinson's diseaseNature, 2000
- Dopaminergic Loss and Inclusion Body Formation in α-Synuclein Mice: Implications for Neurodegenerative DisordersScience, 2000
- α-Synuclein in Lewy bodiesNature, 1997
- Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's diseaseNeurology, 1993
- Rescue of adeno-associated virus from recombinant plasmids: Gene correction within the terminal repeats of AAVCell, 1983
- Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNAJournal of Virology, 1980